Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21

In a study of nine families with "site-specific" ovarian cancer (criterion: three or more cases of epithelial ovarian cancer and no cases of breast cancer diagnosed at age < 50 years) we have obtained evidence of linkage to the breast-ovarian cancer susceptibility gene, BRCA1 on 17q12-2...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of human genetics 1994-11, Vol.55 (5), p.870-875
Hauptverfasser: Steichen-Gersdorf, E, Gallion, H H, Ford, D, Girodet, C, Easton, D F, DiCioccio, R A, Evans, G, Ponder, M A, Pye, C, Mazoyer, S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 875
container_issue 5
container_start_page 870
container_title American journal of human genetics
container_volume 55
creator Steichen-Gersdorf, E
Gallion, H H
Ford, D
Girodet, C
Easton, D F
DiCioccio, R A
Evans, G
Ponder, M A
Pye, C
Mazoyer, S
description In a study of nine families with "site-specific" ovarian cancer (criterion: three or more cases of epithelial ovarian cancer and no cases of breast cancer diagnosed at age < 50 years) we have obtained evidence of linkage to the breast-ovarian cancer susceptibility gene, BRCA1 on 17q12-21. If the risk of cancer in these families is assumed to be restricted to the ovary, the best estimate of the proportion of families linked to BRCA1 is .78 (95% confidence interval .32-1.0). If predisposition to both breast and ovarian cancer is assumed, the proportion linked is 1.0 (95% confidence interval .46-1.0). The linkage of familial site-specific ovarian cancer to BRCA1 indicates the possibility of predictive testing in such families; however, this is only appropriate in families where the evidence for linkage to BRCA1 is conclusive.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1918337</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76851977</sourcerecordid><originalsourceid>FETCH-LOGICAL-p193t-16798cb095089bd95ae461838dc209237fb96fea3efeb72eaabe54b5abfb63f93</originalsourceid><addsrcrecordid>eNpVkM1KAzEURoMotVYfQcjK3UAy6eRnI9RqVSgIouvhJnNHo5lkOpkWfHsVi-jqW3xwDpwDMuWVUIWUrDokU8ZYWZjSqGNykvMbY5xrJiZkooxSYq6n5HoFnQ8eAs1-xCL36HzrHU07GDxE6iA6HKjPNPj4jg0dE716XC44TZFyteFlUfJTctRCyHi23xl5Xt08Le-K9cPt_XKxLnpuxFhwqYx2lpmKaWMbUwHOJddCN65kphSqtUa2CAJbtKpEAIvV3FZgWytFa8SMXP5w-63tsHEYxwFC3Q--g-GjTuDr_0_0r_VL2tXcfGmE-gJc7AFD2mwxj3Xns8MQIGLa5lpJXfHvNDNy_tf0q9h3E5_RS2oo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76851977</pqid></control><display><type>article</type><title>Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Steichen-Gersdorf, E ; Gallion, H H ; Ford, D ; Girodet, C ; Easton, D F ; DiCioccio, R A ; Evans, G ; Ponder, M A ; Pye, C ; Mazoyer, S</creator><creatorcontrib>Steichen-Gersdorf, E ; Gallion, H H ; Ford, D ; Girodet, C ; Easton, D F ; DiCioccio, R A ; Evans, G ; Ponder, M A ; Pye, C ; Mazoyer, S</creatorcontrib><description>In a study of nine families with "site-specific" ovarian cancer (criterion: three or more cases of epithelial ovarian cancer and no cases of breast cancer diagnosed at age &lt; 50 years) we have obtained evidence of linkage to the breast-ovarian cancer susceptibility gene, BRCA1 on 17q12-21. If the risk of cancer in these families is assumed to be restricted to the ovary, the best estimate of the proportion of families linked to BRCA1 is .78 (95% confidence interval .32-1.0). If predisposition to both breast and ovarian cancer is assumed, the proportion linked is 1.0 (95% confidence interval .46-1.0). The linkage of familial site-specific ovarian cancer to BRCA1 indicates the possibility of predictive testing in such families; however, this is only appropriate in families where the evidence for linkage to BRCA1 is conclusive.</description><identifier>ISSN: 0002-9297</identifier><identifier>EISSN: 1537-6605</identifier><identifier>PMID: 7977348</identifier><language>eng</language><publisher>United States</publisher><subject>BRCA1 Protein ; Chromosomes, Human, Pair 17 ; Female ; Genetic Linkage ; Haplotypes ; Humans ; Lod Score ; Neoplasm Proteins - genetics ; Original ; Ovarian Neoplasms - genetics ; Pedigree ; Polymerase Chain Reaction ; Polymorphism, Genetic ; Transcription Factors - genetics</subject><ispartof>American journal of human genetics, 1994-11, Vol.55 (5), p.870-875</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1918337/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1918337/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7977348$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Steichen-Gersdorf, E</creatorcontrib><creatorcontrib>Gallion, H H</creatorcontrib><creatorcontrib>Ford, D</creatorcontrib><creatorcontrib>Girodet, C</creatorcontrib><creatorcontrib>Easton, D F</creatorcontrib><creatorcontrib>DiCioccio, R A</creatorcontrib><creatorcontrib>Evans, G</creatorcontrib><creatorcontrib>Ponder, M A</creatorcontrib><creatorcontrib>Pye, C</creatorcontrib><creatorcontrib>Mazoyer, S</creatorcontrib><title>Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21</title><title>American journal of human genetics</title><addtitle>Am J Hum Genet</addtitle><description>In a study of nine families with "site-specific" ovarian cancer (criterion: three or more cases of epithelial ovarian cancer and no cases of breast cancer diagnosed at age &lt; 50 years) we have obtained evidence of linkage to the breast-ovarian cancer susceptibility gene, BRCA1 on 17q12-21. If the risk of cancer in these families is assumed to be restricted to the ovary, the best estimate of the proportion of families linked to BRCA1 is .78 (95% confidence interval .32-1.0). If predisposition to both breast and ovarian cancer is assumed, the proportion linked is 1.0 (95% confidence interval .46-1.0). The linkage of familial site-specific ovarian cancer to BRCA1 indicates the possibility of predictive testing in such families; however, this is only appropriate in families where the evidence for linkage to BRCA1 is conclusive.</description><subject>BRCA1 Protein</subject><subject>Chromosomes, Human, Pair 17</subject><subject>Female</subject><subject>Genetic Linkage</subject><subject>Haplotypes</subject><subject>Humans</subject><subject>Lod Score</subject><subject>Neoplasm Proteins - genetics</subject><subject>Original</subject><subject>Ovarian Neoplasms - genetics</subject><subject>Pedigree</subject><subject>Polymerase Chain Reaction</subject><subject>Polymorphism, Genetic</subject><subject>Transcription Factors - genetics</subject><issn>0002-9297</issn><issn>1537-6605</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkM1KAzEURoMotVYfQcjK3UAy6eRnI9RqVSgIouvhJnNHo5lkOpkWfHsVi-jqW3xwDpwDMuWVUIWUrDokU8ZYWZjSqGNykvMbY5xrJiZkooxSYq6n5HoFnQ8eAs1-xCL36HzrHU07GDxE6iA6HKjPNPj4jg0dE716XC44TZFyteFlUfJTctRCyHi23xl5Xt08Le-K9cPt_XKxLnpuxFhwqYx2lpmKaWMbUwHOJddCN65kphSqtUa2CAJbtKpEAIvV3FZgWytFa8SMXP5w-63tsHEYxwFC3Q--g-GjTuDr_0_0r_VL2tXcfGmE-gJc7AFD2mwxj3Xns8MQIGLa5lpJXfHvNDNy_tf0q9h3E5_RS2oo</recordid><startdate>199411</startdate><enddate>199411</enddate><creator>Steichen-Gersdorf, E</creator><creator>Gallion, H H</creator><creator>Ford, D</creator><creator>Girodet, C</creator><creator>Easton, D F</creator><creator>DiCioccio, R A</creator><creator>Evans, G</creator><creator>Ponder, M A</creator><creator>Pye, C</creator><creator>Mazoyer, S</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>199411</creationdate><title>Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21</title><author>Steichen-Gersdorf, E ; Gallion, H H ; Ford, D ; Girodet, C ; Easton, D F ; DiCioccio, R A ; Evans, G ; Ponder, M A ; Pye, C ; Mazoyer, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p193t-16798cb095089bd95ae461838dc209237fb96fea3efeb72eaabe54b5abfb63f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>BRCA1 Protein</topic><topic>Chromosomes, Human, Pair 17</topic><topic>Female</topic><topic>Genetic Linkage</topic><topic>Haplotypes</topic><topic>Humans</topic><topic>Lod Score</topic><topic>Neoplasm Proteins - genetics</topic><topic>Original</topic><topic>Ovarian Neoplasms - genetics</topic><topic>Pedigree</topic><topic>Polymerase Chain Reaction</topic><topic>Polymorphism, Genetic</topic><topic>Transcription Factors - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Steichen-Gersdorf, E</creatorcontrib><creatorcontrib>Gallion, H H</creatorcontrib><creatorcontrib>Ford, D</creatorcontrib><creatorcontrib>Girodet, C</creatorcontrib><creatorcontrib>Easton, D F</creatorcontrib><creatorcontrib>DiCioccio, R A</creatorcontrib><creatorcontrib>Evans, G</creatorcontrib><creatorcontrib>Ponder, M A</creatorcontrib><creatorcontrib>Pye, C</creatorcontrib><creatorcontrib>Mazoyer, S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of human genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Steichen-Gersdorf, E</au><au>Gallion, H H</au><au>Ford, D</au><au>Girodet, C</au><au>Easton, D F</au><au>DiCioccio, R A</au><au>Evans, G</au><au>Ponder, M A</au><au>Pye, C</au><au>Mazoyer, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21</atitle><jtitle>American journal of human genetics</jtitle><addtitle>Am J Hum Genet</addtitle><date>1994-11</date><risdate>1994</risdate><volume>55</volume><issue>5</issue><spage>870</spage><epage>875</epage><pages>870-875</pages><issn>0002-9297</issn><eissn>1537-6605</eissn><abstract>In a study of nine families with "site-specific" ovarian cancer (criterion: three or more cases of epithelial ovarian cancer and no cases of breast cancer diagnosed at age &lt; 50 years) we have obtained evidence of linkage to the breast-ovarian cancer susceptibility gene, BRCA1 on 17q12-21. If the risk of cancer in these families is assumed to be restricted to the ovary, the best estimate of the proportion of families linked to BRCA1 is .78 (95% confidence interval .32-1.0). If predisposition to both breast and ovarian cancer is assumed, the proportion linked is 1.0 (95% confidence interval .46-1.0). The linkage of familial site-specific ovarian cancer to BRCA1 indicates the possibility of predictive testing in such families; however, this is only appropriate in families where the evidence for linkage to BRCA1 is conclusive.</abstract><cop>United States</cop><pmid>7977348</pmid><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9297
ispartof American journal of human genetics, 1994-11, Vol.55 (5), p.870-875
issn 0002-9297
1537-6605
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1918337
source MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects BRCA1 Protein
Chromosomes, Human, Pair 17
Female
Genetic Linkage
Haplotypes
Humans
Lod Score
Neoplasm Proteins - genetics
Original
Ovarian Neoplasms - genetics
Pedigree
Polymerase Chain Reaction
Polymorphism, Genetic
Transcription Factors - genetics
title Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T21%3A36%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Familial%20site-specific%20ovarian%20cancer%20is%20linked%20to%20BRCA1%20on%2017q12-21&rft.jtitle=American%20journal%20of%20human%20genetics&rft.au=Steichen-Gersdorf,%20E&rft.date=1994-11&rft.volume=55&rft.issue=5&rft.spage=870&rft.epage=875&rft.pages=870-875&rft.issn=0002-9297&rft.eissn=1537-6605&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E76851977%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76851977&rft_id=info:pmid/7977348&rfr_iscdi=true